PT Multi Medika Internasional Tbk (ISX:MMIX) Current Deferred Revenue: Rp0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MMIX PT Multi Medika Internasional Tbk ISX:MMIX
24 GF Score
Price Rp850.00
View Full Analysis

What is PT Multi Medika Internasional Tbk Current Deferred Revenue?

PT Multi Medika Internasional Tbk ISX:MMIX +1.80% 24 Current Deferred Revenue is Rp0 Mil as of Jun. 2026. GuruFocus rates ISX:MMIX with a GF Score™ of 24/100.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

PT Multi Medika Internasional Tbk's current deferred revenue for the quarter that ended in Jun. 2026 was Rp0 Mil.

PT Multi Medika Internasional Tbk Current Deferred Revenue Related Terms


PT Multi Medika Internasional Tbk Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for PT Multi Medika Internasional Tbk's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Multi Medika Internasional Tbk Current Deferred Revenue Chart

PT Multi Medika Internasional Tbk Annual Data
Trend Dec20 Dec21
Current Deferred Revenue
0.00 0.00

PT Multi Medika Internasional Tbk Semi-Annual Data
Dec20 Dec21 Jun25 Jun26
Current Deferred Revenue 0.00 0.00 0.00 0.00
ISX:MMIX
24GF Score
PT Multi Medika Internasional Tbk ISX:MMIX
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of Rp0 Mil mean?
PT Multi Medika Internasional Tbk (ISX:MMIX) has a Current Deferred Revenue of Rp0 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on PT Multi Medika Internasional Tbk and its competitors.
Is PT Multi Medika Internasional Tbk's Current Deferred Revenue too high?
PT Multi Medika Internasional Tbk's current Current Deferred Revenue is Rp0 Mil. Overall, PT Multi Medika Internasional Tbk has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does PT Multi Medika Internasional Tbk's Current Deferred Revenue compare to competitors?
PT Multi Medika Internasional Tbk's Current Deferred Revenue of Rp0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on PT Multi Medika Internasional Tbk and its competitors. PT Multi Medika Internasional Tbk's current Current Deferred Revenue is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Multi Medika Internasional Tbk stock overvalued right now?
PT Multi Medika Internasional Tbk (ISX:MMIX) has a current Current Deferred Revenue of Rp0 Mil. The current Current Deferred Revenue is Rp0 Mil. PT Multi Medika Internasional Tbk's overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For PT Multi Medika Internasional Tbk (ISX:MMIX), the current Current Deferred Revenue is Rp0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Multi Medika Internasional Tbk Business Description

Address Jl. Peternakan III No.55B, Kelurahan Kapuk, Kecamatan Cengkareng, Jakarta Barat, DKI Jakarta, Kode Pos, Jakarta, IDN, 11720
PT Multi Medika Internasional Tbk is engaged in the wholesale trading of medical devices and pharmaceutical and laboratory equipment for humans, operating lease, and non-copyrighted works. It also wholesales other food and beverages, such as rice flour, tapioca flour, bakery premix, caramel, processed honey, shrimp crackers and others; agricultural food and beverages, such as herbs and spices; livestock and fisheries; non-alcoholic beverages, such as fruit juice, soft drinks, mineral water, bottled water, and other similar products; cosmetics for humans such as perfume, soap, powder and others. Its segments include Mask and other non food and beverages, and food and beverages. It derives the majoritf of the revenue from Mask and other non food and beverages segments.
24GF Score

Get the complete analysis for ISX:MMIX

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp850.00
Price